As the clock ticks down on the current term there are significant differences of opinion to reconcile if new pharmaceutical legislation is to be agreed before proceedings are suspended for the 2024 elections. Tensions are high in the European Parliament as MEPs scrutinise proposed – and opposing - changes to the Commission’s draft, that have been put forward by rapporteurs Pernille Weiss of EPP and S&D’s Tiemo Wölken.